| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/05/2003 | EP1286677A1 Purified material having size and growth inhibitory effects on cells and tissues |
| 03/05/2003 | EP1286673A2 Ligands of integrin receptors |
| 03/05/2003 | EP1286655A1 Topical composition containing at least one aryl oxime, and method for the preparation thereof |
| 03/05/2003 | EP1286654A1 Use of aryl oximes for the prophylaxis and/or treatment of erythema formation and/or inflammatory reactions of the skin |
| 03/05/2003 | EP1286653A1 Composition containing at least one aryl oxime and at least one active substance for treating acne and the use thereof |
| 03/05/2003 | EP1286652A2 Skin protectant spray compositions |
| 03/05/2003 | EP1140972B1 New 7-alpha, 17-alpha-bis-alkylated testosterone derivatives and their use in long-term therapy of androgen-dependent diseases |
| 03/05/2003 | EP1115719B1 Novel amidine derivatives, their preparation and application as medicines and pharmaceutical compositions containing same |
| 03/05/2003 | EP1079826B1 Use of indigoid bisindole derivatives for the manufacture of a medicament to inhibit cyclin dependent kinases |
| 03/05/2003 | EP1062214B1 Substituted 2-(2,6-dioxo-3-fluoropiperidin-3-yl)-isoindolines and their use to reduce tnfa levels |
| 03/05/2003 | EP1051410B1 Benzo[b]pyran derivatives useful as external agents for the skin |
| 03/05/2003 | EP0966447B1 Small molecules useful in the treatment of inflammatory disease |
| 03/05/2003 | EP0964865B1 Pharmaceutically active tricyclic amines |
| 03/05/2003 | EP0932387B1 Skin care compositions containing combinations of compounds for mimicking the effect on skin of retinoic acid |
| 03/05/2003 | EP0892791B1 N-[[4-(5-METHYL-3-PHENYLISOXAZOL-4-YL]PHENYL]SULFONYLPROPYLAMIDE and its SODIUMSALT AS PRODRUGS OF COX-2 INHIBITORS |
| 03/05/2003 | EP0892633B1 Use of inhibitors of the activity of retinoic acid for treating sensitive skin and/or acute damage induced by uv radiation |
| 03/05/2003 | EP0831830B1 Imidazole compounds |
| 03/05/2003 | EP0667784B1 Inhibitors of cell regulatory factors and methods for preventing or reducing scarring |
| 03/05/2003 | EP0554352B1 A method for transplanting cells into the brain and therapeutic uses therefor |
| 03/05/2003 | CN1400975A 嘌呤衍生物 Purine derivatives |
| 03/05/2003 | CN1400973A Novel biarylcarboxamides |
| 03/05/2003 | CN1400968A Method for preparing alpha sulfonyl hydroxamic acid derivatives |
| 03/05/2003 | CN1400898A 回旋酶抑制剂及其用途 Gyrase inhibitors and their use |
| 03/05/2003 | CN1400871A Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability of undesired permeability of the |
| 03/05/2003 | CN1399997A Liquid method for growing hair |
| 03/05/2003 | CN1399984A Prescription of medicine for curing scald and its preparation method |
| 03/05/2003 | CN1399978A Chinese medicine liquor for curing pointed condyloma |
| 03/05/2003 | CN1399971A Biological preparation for curing burn and its preparation method |
| 03/05/2003 | CN1399967A Wound healing ointment |
| 03/05/2003 | CN1399957A Application of shikonin and its derivative in pharmaceutical industry |
| 03/05/2003 | CN1399951A Easily transdermal membrane capable of promoting regrowth of delicate skin and its preparation method |
| 03/05/2003 | CN1102593C N-[4(heteroarylmethyl)phenyl]-heteroarylamines compound |
| 03/05/2003 | CN1102573C Aryl or heteroaryl substd, 3,4-dihydroanthracene and benzo [1,2-g]-chrom-3-ene, benzo[1,2-g]-thiochrom-3-ene and benzo [1,2-g]-1,2-dihydroquinoline derivs having bioactivity of visual pigmentoid |
| 03/05/2003 | CN1102406C Medicine for treating burn (scald) and preparation process |
| 03/05/2003 | CN1102401C Repellent antipruritic liquidf or mosquito bite |
| 03/05/2003 | CN1102376C Improved anti dandruff shampoo |
| 03/05/2003 | CA2421283A1 Novel mmp-2 derivatives for use as inhibitors of integrin .alpha.v.beta.3 |
| 03/04/2003 | WO2002022148A1 Wild apple polyphenol and process for producing the same |
| 03/04/2003 | US6528677 Selective retinoid agonists |
| 03/04/2003 | US6528526 Inhibition of cell proliferation and/or cell matrix production and/or cell movement (chemotaxis) and/or T cell activation and proliferation |
| 03/04/2003 | US6528512 Cytokine specific binding protein; |
| 03/04/2003 | US6528509 Pyrazole compositions useful as inhibitors of ERK |
| 03/04/2003 | US6528508 A bicyclic nitrogen containing heteroaromatic compound useful for inhibiting protein kinase p38 which involved in cell proliferation, cell death and response to extracellular stimuli |
| 03/04/2003 | US6528490 Plant extracts; free radical scavengers; antiinflammatory agents |
| 03/04/2003 | US6528294 To effect protein phosphorylation; for use in diagnosis and therapy |
| 03/04/2003 | US6528096 Carrier mixed with additives having lubricant properties for preparing powdery pharmaceutical compositions for inhalation |
| 03/04/2003 | US6528086 Methods and apparatus for drug delivery involving phase changing formulations |
| 03/04/2003 | US6528074 Lipid composition containing a liquid crystal structure |
| 03/04/2003 | US6528040 EMU oil-based formulations for use as an analgesic, anesthetic and antipruritic |
| 03/04/2003 | CA1341424C Diketohexanoic acids and 2- and 3-diloweralkyl derivatives thereof |
| 03/03/2003 | WO2002019971A1 4-halogenated 17-methylene steroids, method for the production thereof and pharmaceutical compositions containing these compounds |
| 03/01/2003 | WO2003000027A2 Blocking peptide for inflammatory cell secretion |
| 03/01/2003 | CA2452123A1 Blocking peptide for inflammatory cell secretion |
| 02/27/2003 | WO2003016916A1 Identification and isolation of somatic stem cells and uses thereof |
| 02/27/2003 | WO2003016549A2 Nucleic-acid associated proteins |
| 02/27/2003 | WO2003016520A1 Anti-aging and wound healing compounds |
| 02/27/2003 | WO2003016505A2 Kgf polypeptide compositions |
| 02/27/2003 | WO2003016468A2 Antagonistic anti-htnfsf13b human antibodies |
| 02/27/2003 | WO2003016351A2 N - cam related compounds modulating cell groth |
| 02/27/2003 | WO2003016335A2 Irreversible cysteine protease inhibitors of legumain |
| 02/27/2003 | WO2003016314A1 1-alkyl 0r 1-cycloalkyltriazolo[4,3-a]quinazolin-5-ones as phosphodiesterase inhibitors |
| 02/27/2003 | WO2003016305A1 Crystals including a malic acid salt of n-[2-(diethylamino) ethyl]-5-[(5-fluoro-2-oxo-3h-indole-3-ylidene) methyl]-2, 4-dimethyl-1h-pyrrole-3-carboxamide, processes for its preparation and compositions thereof |
| 02/27/2003 | WO2003016289A1 Triazine derivatives and their use as sunscreens |
| 02/27/2003 | WO2003016279A1 Fused-polycyclic compounds |
| 02/27/2003 | WO2003015809A2 Antimicrobial cationic peptides and formulations thereof |
| 02/27/2003 | WO2003015805A1 Composition for removal of toxins |
| 02/27/2003 | WO2003015799A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and chondroitin sulfate |
| 02/27/2003 | WO2003015797A1 Compositions for the treatment and prevention of pain and inflammation with a cyclooxygenase-2 selective inhibitor and glucosamine |
| 02/27/2003 | WO2003015789A2 A pharmaceutical composition for dermal application |
| 02/27/2003 | WO2003015784A1 2-substituted 1-arylpiperazines as tachykinin antagonists and/or serotonin reuptake inhibitors |
| 02/27/2003 | WO2003015776A1 2,4,5-trisubstituted thiazolyl derivatives and their antiinflammatory activity |
| 02/27/2003 | WO2003015767A2 Use of tectorigenin for the production of cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions and/or for skin protection of determinate sensitive and dry skin |
| 02/27/2003 | WO2003015759A2 Treatment of hyperproliferative conditions of body surfaces |
| 02/27/2003 | WO2003015757A1 Synthesis and use of reagents for improved dna lipofection and/or slow release prodrug and drug therapies |
| 02/27/2003 | WO2003015755A1 Lipidated glycosaminoglycan particles and their use in drug and gene delivery for diagnosis and therapy |
| 02/27/2003 | WO2003015748A2 Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds |
| 02/27/2003 | WO2003015744A1 Chitin microparticles and their medical uses |
| 02/27/2003 | WO2003015741A1 Humectant and cosmetics and external preparations containing the same |
| 02/27/2003 | WO2003015737A1 Use of oroxylin a for the production of cosmetic or dermatological preparations for the prophylaxis and treatment of inflammatory skin conditions and/or for skin protection of determinate sensitive and dry skin |
| 02/27/2003 | WO2003015729A1 Topical composition for follicular delivery of an ornithine decarboxylase inhibitor |
| 02/27/2003 | WO2003015724A1 Substances capable of potentiating laminin 5 productivity in epidermal cells and utilization thereof |
| 02/27/2003 | WO2003015692A2 Crystallized glucocorticoid receptor ligand binding domain polypeptide and screening methods employing same |
| 02/27/2003 | WO2003015494A2 Tocopherol enriched compositions and amelioration of inflammatory symptoms |
| 02/27/2003 | WO2003004098A8 Composition for topical administration comprising an interleukin-2 inhibitor and an antimicrobial agent |
| 02/27/2003 | WO2002098278A3 Peripheral blood fibrocytes differentiation pathway and migration to wound sites |
| 02/27/2003 | WO2002097046A3 B7 related protein-2 molecules and uses thereof |
| 02/27/2003 | WO2002092588A3 Aromatic sulfone hydroxamates and their use as protease inhibitors |
| 02/27/2003 | WO2002092129A3 Pharmaceutical combination comprising an anti-androgen and an oestrogen receptor beta agonist |
| 02/27/2003 | WO2002090325A3 Benzazepinone alpha v integrin receptor antagonists |
| 02/27/2003 | WO2002087511A3 Modulators of elastase inhibitor secretion |
| 02/27/2003 | WO2002076401A3 Method of attenuating reactions to skin irritants |
| 02/27/2003 | WO2002072018A3 A cream-t0-powder dermatological composition |
| 02/27/2003 | WO2002066420A3 Tryptase inhibitors |
| 02/27/2003 | WO2002060388A3 Acyl sulfamides for treatment of obesity, diabetes and lipid disorders |
| 02/27/2003 | WO2002046193A3 Heterocyclic ether substituted imidazoquinolines |
| 02/27/2003 | WO2002022212A3 Combination therapy for treatment of autoimmune diseases using b cell depleting/immunoregulatory antibody combination |
| 02/27/2003 | WO2001098481A3 Renal regulatory elements and methods of use thereof |
| 02/27/2003 | WO2001098267A8 3-azabicyclo (3.1.0) hexane derivatives having opioid receptor affinity |
| 02/27/2003 | WO2001093889A3 Vip-related peptides for the treatment of skin disorders |
| 02/27/2003 | US20030040640 For use as anti- inflammatory analgesics, in therapy of immune disorders, as anti- cancer and anti-tumor agents, and therapy of cardiovascular disease, skin redness, and viral infection |